1. Home
  2. BDSX vs BTMD Comparison

BDSX vs BTMD Comparison

Compare BDSX & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • BTMD
  • Stock Information
  • Founded
  • BDSX 2005
  • BTMD 2012
  • Country
  • BDSX United States
  • BTMD United States
  • Employees
  • BDSX N/A
  • BTMD N/A
  • Industry
  • BDSX Precision Instruments
  • BTMD Medicinal Chemicals and Botanical Products
  • Sector
  • BDSX Health Care
  • BTMD Health Care
  • Exchange
  • BDSX Nasdaq
  • BTMD Nasdaq
  • Market Cap
  • BDSX 245.3M
  • BTMD 224.1M
  • IPO Year
  • BDSX 2020
  • BTMD N/A
  • Fundamental
  • Price
  • BDSX $1.60
  • BTMD $5.17
  • Analyst Decision
  • BDSX Strong Buy
  • BTMD Strong Buy
  • Analyst Count
  • BDSX 4
  • BTMD 4
  • Target Price
  • BDSX $3.08
  • BTMD $8.39
  • AVG Volume (30 Days)
  • BDSX 118.2K
  • BTMD 113.4K
  • Earning Date
  • BDSX 11-01-2024
  • BTMD 11-05-2024
  • Dividend Yield
  • BDSX N/A
  • BTMD N/A
  • EPS Growth
  • BDSX N/A
  • BTMD N/A
  • EPS
  • BDSX N/A
  • BTMD 0.20
  • Revenue
  • BDSX $60,902,000.00
  • BTMD $187,233,000.00
  • Revenue This Year
  • BDSX $48.06
  • BTMD $11.02
  • Revenue Next Year
  • BDSX $29.97
  • BTMD $14.99
  • P/E Ratio
  • BDSX N/A
  • BTMD $26.30
  • Revenue Growth
  • BDSX 46.25
  • BTMD 3.70
  • 52 Week Low
  • BDSX $1.15
  • BTMD $3.65
  • 52 Week High
  • BDSX $2.21
  • BTMD $8.44
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 39.90
  • BTMD 39.81
  • Support Level
  • BDSX $1.59
  • BTMD $5.16
  • Resistance Level
  • BDSX $1.68
  • BTMD $5.49
  • Average True Range (ATR)
  • BDSX 0.06
  • BTMD 0.19
  • MACD
  • BDSX -0.01
  • BTMD 0.03
  • Stochastic Oscillator
  • BDSX 20.51
  • BTMD 42.34

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About BTMD Biote Corp.

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations.

Share on Social Networks: